.AN2 Therapies is actually reassessing its service in reaction to poor midphase information, promisi...
.Merck & Co. is actually paying out $700 million upfront to test Amgen in a blood cancer market. ...
.With Gilead Sciences on the verge of an FDA decision for its liver disease drug seladelpar, the pro...
.CEO David Ricks may observe the providers putting together tents at basecamp behind Eli Lilly in an...
.Mattress Liquidators has actually turned Entero Therapeutics white as a sheet. The lender ordered E...
.Exelixis is giving up on its cells variable (TF)- targeting antibody-drug conjugate after concludin...
.3 full weeks after Roche's Genentech device bowed out an SHP2 prevention contract, Relay Therapeuti...
.Stoke Rehabs' Dravet syndrome medication has actually been freed from a predisposed hold, removing ...
.Strong Biotech Associate Editor Gabrielle Masson offered the 2024 course of Tough 15 victors on the...
.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) advancemen...